Patents by Inventor Dorotea Raventos Segura

Dorotea Raventos Segura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDES HAVING XANTHAN DEGRADING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20180171315
    Abstract: The present invention relates to polypeptides having xanthan degrading activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: September 15, 2016
    Publication date: June 21, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Dorotea Raventos Segura, Lars Anderson, Lorena Gonzalez Palmen, Liv Spaangner Christiansen, Peter Fischer Hallin, Leigh Murphy, Mette Louise Dissing Overgaard, Rune Nygaard Monrad, Timothy O'Connell, Susanne Tondera, Nina Mussman, Daniela Herbst
  • Polypeptides having xanthan degrading activity and polynucleotides encoding same
    Patent number: 9988616
    Abstract: The present invention relates to isolated polypeptides having xanthan degrading activity, catalytic domains and polynucleotides encoding the polypeptides and catalytic domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides and catalytic domains.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: June 5, 2018
    Assignee: NOVOZYMES A/S
    Inventors: Dorotea Raventos Segura, Peter Fischer Halin, Anders Viksoe-Nielsen, Lars Anderson, Martin Simon Borchert, Leigh Murphy, Astrid Boisen, Lorena G. Palmen, Kenneth Jensen, Carsten Sjoeholm, Tine Hoff, Charlotte Blom
  • Polypeptides having Xylanase Activity and Polynucleotides Encoding Same
    Publication number: 20170202242
    Abstract: The present invention relates to polypeptides having xylanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. The invention also relates to compositions comprising the polypeptides of the invention and the use of the polypeptides of the invention to release xylose and in animal feed.
    Type: Application
    Filed: July 9, 2015
    Publication date: July 20, 2017
    Applicant: Novozymes A/S
    Inventors: Charlotte Blom, Ninfa Rangel Pedersen, Dan Pettersson, Jens Magnus Eklof, Kristian Bertel Roemer Krogh, Martin Simon Borchert, Dorotea Raventos Segura, Nele Ilmberger, Wolfgang Streit, Jesper Salomon
  • Polypeptides Having Phospholipase C Activity and Polynucleotides Encoding Same
    Publication number: 20170096619
    Abstract: The present invention relates to a method of reducing the phospholipid content in an oil or fat composition and polypeptides having PI-specific phospholipase C activity as well as polypeptides having PC, PE-specific phospholipase C activity and combinations thereof capable of catalyzing this reduction. The invention also relates to polynucleotides encoding the polypeptides, nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: March 19, 2015
    Publication date: April 6, 2017
    Applicant: Novozymes A/S
    Inventors: Dorotea Raventos Segura, Robert Piotr Olinski, Kim Borch, Allan Noergaard, Jesper Brask, Rune Falkenberg Haller, Marianne Linde Damstrup
  • Polypeptides Having Xanthan Degrading Activity and Polynucleotides Encoding Same
    Publication number: 20170073656
    Abstract: The present invention relates to isolated polypeptides having xanthan degrading activity, catalytic domains and polynucleotides encoding the polypeptides and catalytic domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides and catalytic domains.
    Type: Application
    Filed: August 24, 2016
    Publication date: March 16, 2017
    Applicant: Novozymes A/S
    Inventors: Dorotea Raventos Segura, Peter Fischer Halin, Anders Viksoe-Nielsen, Lars Anderson, Martin Simon Borchert, Leigh Murphy, Astrid Boisen, Lorena G. Palmen, Kenneth Jensen, Carsten Sjoeholm, Tine Hoff, Charlotte Blom
  • Polypeptides having xanthan degrading activity and polynucleotides encoding same
    Patent number: 9458441
    Abstract: The present invention relates to isolated polypeptides having xanthan degrading activity, catalytic domains and polynucleotides encoding the polypeptides and catalytic domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides and catalytic domains.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: October 4, 2016
    Assignee: Novozymes A/S
    Inventors: Dorotea Raventos Segura, Peter Fischer Halin, Lars Anderson, Martin Simon Borchert, Leigh Murphy, Astrid Boisen, Lorena G. Palmen, Kenneth Jensen, Carsten Sjoeholm, Tine Hoff, Charlotte Blom, Anders Viksoe-Nielsen
  • Antimicrobial Peptide Variants and Polynucleotides Encoding Same
    Publication number: 20160158317
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: February 13, 2016
    Publication date: June 9, 2016
    Applicant: Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Polypeptides Having Xanthan Degrading Activity and Polynucleotides Encoding Same
    Publication number: 20150132824
    Abstract: The present invention relates to isolated polypeptides having xanthan degrading activity, catalytic domains and polynucleotides encoding the polypeptides and catalytic domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides and catalytic domains.
    Type: Application
    Filed: May 7, 2013
    Publication date: May 14, 2015
    Inventors: Dorotea Raventos Segura, Peter Fischer Halin, Anders Viksoe-Nielsen, Lars Anderson, Martin Simon Borchert, Leigh Murphy, Astrid Boisen, Lorena G. Palmén, Kenneth Jensen, Carsten Sjoeholm, Tine Hoff, Charlotte Blom
  • Antimicrobial Peptide Variants and Polynucleotides Encoding Same
    Publication number: 20150031601
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: August 11, 2014
    Publication date: January 29, 2015
    Applicant: ADDENIUM BIOTECH APS
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Antimicrobial peptide variants and polynucleotides encoding same
    Patent number: 8835604
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: September 16, 2014
    Assignee: Adenium Biotech Aos
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Use of AMPs for treatment of UTI/cystitis
    Patent number: 8653024
    Abstract: Provided is treatment of urinary tract infections including bladder infections caused by uropathogenic bacterial strains such as for example Escherichia coli with a beta-hairpin antimicrobial Arenicin polypeptide derived from the murine polychaeta Arenicola marina. Also provided are variants of Arenicin for treatment of urinary tract infections.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: February 18, 2014
    Assignee: Adenium Biotech Aps
    Inventors: Birgitte Thue Ravn, Karoline Sidelmann Brinch, Dorthe Hoej Sandvang, Hans-Henrik Kristensen Hoegenhaug, Dorotea Raventos Segura, Soeren Neve
  • Antimicrobial polypeptides
    Patent number: 8080390
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: December 20, 2011
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • ANTIMICROBIAL PEPTIDE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20110306750
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 2, 2011
    Publication date: December 15, 2011
    Applicant: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Antimicrobial polypeptides from
    Patent number: 7972814
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: July 5, 2011
    Inventors: Kirk Matthew Schnorr, Mogens Trier Hansen, Per Holse Mygind, Dorotea Raventos Segura, Hans-Henrik Hogenhaug Kristensen
  • Polypeptides having Antimicrobial Activity and Polynucleotides Encoding Same
    Publication number: 20110160122
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 5, 2011
    Publication date: June 30, 2011
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Use of AMPs for Treatment of UTI/Cystitis
    Publication number: 20110144002
    Abstract: The present invention relates to methods for treating urinary tract infections, such as cystitis, with antimicrobial polypeptides polypeptides.
    Type: Application
    Filed: December 3, 2010
    Publication date: June 16, 2011
    Applicant: NOVOZYMES A/S
    Inventors: BIRGITTE THUE RAVN, KAROLINE SIDELMANN BRINCH, DORTHE HOEJ SANDVANG, HANS-HENRIK KIRSTENSEN HOEGENHAUG, DOROTEA RAVENTOS SEGURA, SOEREN NEVE
  • USE OF DEFENSINS AGAINST TUBERCULOSIS
    Publication number: 20110053836
    Abstract: The present invention relates to a method for killing or inhibiting cells of Mycobacterium, in particular M. tuberculosis, with certain defensins.
    Type: Application
    Filed: November 2, 2010
    Publication date: March 3, 2011
    Applicant: NOVOZYMES ADENIUM BIOTECH A/S
    Inventors: HANS-HENRIK KRISTENSEN HOGENHAUG, GARY K. SCHOOLNIK, SIDHARTH CHOPRA, DOROTEA RAVENTOS SEGURA
  • Polypeptides having antimicrobial activity and polynucleotides encoding same
    Patent number: 7893196
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 19, 2005
    Date of Patent: February 22, 2011
    Assignee: Novozymes Aderium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Antimicrobial peptides
    Patent number: 7829524
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: November 9, 2010
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Hans-Henrik Kristensen Hoegenhaug, Alessandro Tossi
  • Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same
    Publication number: 20100120690
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 14, 2010
    Publication date: May 13, 2010
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Jesper Vind, Dorotea Raventos Segura, Hans-Henrik Kristensen Hoegenhaug, Per Hose Mygind, Olivier Taboureau